| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |